ClinicalCodes.org
An online clinical codes repository to improve validity and reproducibility of medical database research
Research article:
Clinical management following self-harm in a UK-wide primary care cohort
Reference:
Matthew J Carr, Darren M Ashcroft, Evan Kontopantelis, David While, Yvonne Awenat, Jayne Cooper, Carolyn Chew-Graham, Nav Kapur, Roger T Webb(2016) Clinical management following self-harm in a UK-wide primary care cohort. Journal of Affective Disorders, doi:
- Link to article
- Abstract
- Background: Little is known about the clinical management of patients in primary care following self-harm. Methods: A descriptive cohort study using data from 684 UK general practices that contributed to the Clinical Practice Research Datalink (CPRD) during 2001-2013. We identified 49,970 patients with a self-harm episode, 41,500 of whom had one complete year of follow-up. Results: Among those with complete follow-up, 26,065 (62.8%, 62.3-63.3) were prescribed psychotropic medication and 6,318 (15.2%, 14.9-15.6) were referred to mental health services; 4,105 (9.9%, CI 9.6-10.2) were medicated without an antecedent psychiatric diagnosis or referral, and 4,506 (10.9%, CI 10.6-11.2) had a diagnosis but were not subsequently medicated or referred. Patients registered at practices in the most deprived localities were 27.1% (CI 21.5-32.2) less likely to be referred than those in the least deprived. Despite a specifically flagged NICE ‘Do not do’ recommendation in 2011 against prescribing tricyclic antidepressants following self-harm because of their potentially lethal toxicity in overdose, 8.8% (CI 7.8-9.8) of individuals were issued a prescription in the subsequent year. The percentage prescribed Citalopram, an SSRI antidepressant with higher toxicity in overdose, fell sharply during 2012/2013 in the aftermath of a Medicines and Healthcare products Regulatory Agency (MHRA) safety alert issued in 2011. Conclusions: A relatively small percentage of these vulnerable patients are referred to mental health services, and reduced likelihood of referral in more deprived localities reflects a marked health inequality. National clinical guidelines have not yet been effective in reducing rates of tricyclic antidepressant prescribing for this high-risk group.
- Author for correspondence
- Matthew J Carr
- Email for correspondence
- matthew.carr@manchester.ac.uk
Code list: res36: Atypical APDs
173 codes in list
| Code | Coding system | Description | Entity type | List name | |||
|---|---|---|---|---|---|---|---|
| 00209021 | Multilex | Quetiapine 12.5mg/5ml oral solution | drug | res36: Atypical APDs | |||
| 00337021 | Multilex | Asenapine 5mg sublingual tablets sugar free | drug | res36: Atypical APDs | |||
| 00341021 | Multilex | Asenapine 10mg sublingual tablets sugar free | drug | res36: Atypical APDs | |||
| 00411021 | Multilex | Amisulpride 25mg/5ml oral solution | drug | res36: Atypical APDs | |||
| 00447021 | Multilex | Quetiapine 12.5mg/5ml oral suspension | drug | res36: Atypical APDs | |||
| 00589021 | Multilex | Zalasta 5mg orodispersible tablets (Consilient Health Ltd) | drug | res36: Atypical APDs | |||
| 00709021 | Multilex | Olanzapine 5mg orodispersible tablets sugar free | drug | res36: Atypical APDs | |||
| 00711021 | Multilex | Olanzapine 5mg orodispersible tablets | drug | res36: Atypical APDs | |||
| 00713021 | Multilex | Olanzapine 5mg oral lyophilisates sugar free | drug | res36: Atypical APDs | |||
| 00715021 | Multilex | Olanzapine 10mg orodispersible tablets sugar free | drug | res36: Atypical APDs | |||
| 00717021 | Multilex | Olanzapine 10mg orodispersible tablets | drug | res36: Atypical APDs | |||
| 00719021 | Multilex | Olanzapine 10mg oral lyophilisates sugar free | drug | res36: Atypical APDs | |||
| 00723021 | Multilex | Olanzapine 15mg orodispersible tablets sugar free | drug | res36: Atypical APDs | |||
| 00725021 | Multilex | Olanzapine 15mg orodispersible tablets | drug | res36: Atypical APDs | |||
| 00727021 | Multilex | Olanzapine 15mg oral lyophilisates sugar free | drug | res36: Atypical APDs | |||
| 00729021 | Multilex | Olanzapine 20mg orodispersible tablets sugar free | drug | res36: Atypical APDs | |||
| 00731021 | Multilex | Olanzapine 20mg orodispersible tablets | drug | res36: Atypical APDs | |||
| 00733021 | Multilex | Olanzapine 20mg oral lyophilisates sugar free | drug | res36: Atypical APDs | |||
| 03580020 | Multilex | Olanzapine 2.5mg tablets (Aspire Pharma Ltd) | drug | res36: Atypical APDs | |||
| 10469020 | Multilex | Abilify 5mg tablets (Sigma Pharmaceuticals Plc) | drug | res36: Atypical APDs | |||
| 13768020 | Multilex | Risperdal Consta 50mg powder and solvent for suspension for injection vials (Waymade Healthcare Plc) | drug | res36: Atypical APDs | |||
| 33610020 | Multilex | Quetiapine 25mg/5ml oral solution | drug | res36: Atypical APDs | |||
| 35008020 | Multilex | Amisulpride 12.5mg/5ml oral solution | drug | res36: Atypical APDs | |||
| 35010020 | Multilex | Amisulpride 12.5mg/5ml oral suspension | drug | res36: Atypical APDs | |||
| 36328020 | Multilex | Quetiapine 50mg/5ml oral suspension | drug | res36: Atypical APDs | |||
| 36905020 | Multilex | Risperidone 125micrograms/5ml oral solution | drug | res36: Atypical APDs | |||
| 42176020 | Multilex | Quetiapine 25mg tablets (Zentiva) | drug | res36: Atypical APDs | |||
| 49437020 | Multilex | Risperdal 1mg tablets (Janssen-Cilag Ltd) | drug | res36: Atypical APDs | |||
| 49438020 | Multilex | Risperdal 2mg tablets (Janssen-Cilag Ltd) | drug | res36: Atypical APDs | |||
| 49439020 | Multilex | Risperdal 3mg tablets (Janssen-Cilag Ltd) | drug | res36: Atypical APDs | |||
| 49489020 | Multilex | Risperidone 4mg tablets | drug | res36: Atypical APDs | |||
| 49490020 | Multilex | Risperidone 1mg/ml oral solution sugar free | drug | res36: Atypical APDs | |||
| 49491020 | Multilex | Risperidone 6mg tablets | drug | res36: Atypical APDs | |||
| 50780020 | Multilex | Zotepine 25mg tablets | drug | res36: Atypical APDs | |||
| 50781020 | Multilex | Zotepine 50mg tablets | drug | res36: Atypical APDs | |||
| 50782020 | Multilex | Zotepine 100mg tablets | drug | res36: Atypical APDs | |||
| 53727020 | Multilex | Risperidone 1mg tablets | drug | res36: Atypical APDs | |||
| 53728020 | Multilex | Risperidone 2mg tablets | drug | res36: Atypical APDs | |||
| 53729020 | Multilex | Risperidone 3mg tablets | drug | res36: Atypical APDs | |||
| 55209020 | Multilex | Zoleptil 25 tablets (Movianto UK Ltd) | drug | res36: Atypical APDs | |||
| 55210020 | Multilex | Zoleptil 50 tablets (Movianto UK Ltd) | drug | res36: Atypical APDs | |||
| 55972020 | Multilex | Olanzapine 15mg Orodispersible tablet | drug | res36: Atypical APDs | |||
| 58203020 | Multilex | Zyprexa 15mg tablets (Eli Lilly and Company Ltd) | drug | res36: Atypical APDs | |||
| 59434020 | Multilex | Olanzapine 15mg tablets | drug | res36: Atypical APDs | |||
| 65788020 | Multilex | Risperidone 50mg powder and solvent for suspension for injection vials | drug | res36: Atypical APDs | |||
| 68217020 | Multilex | Amisulpride 50mg tablets (Zentiva) | drug | res36: Atypical APDs | |||
| 68222020 | Multilex | Amisulpride 100mg tablets (Zentiva) | drug | res36: Atypical APDs | |||
| 68224020 | Multilex | Amisulpride 200mg tablets (Zentiva) | drug | res36: Atypical APDs | |||
| 69302020 | Multilex | Amisulpride 200mg tablets (A A H Pharmaceuticals Ltd) | drug | res36: Atypical APDs | |||
| 72576020 | Multilex | Clozaril 25mg tablets (Novartis Pharmaceuticals UK Ltd) | drug | res36: Atypical APDs | |||
| 72577020 | Multilex | Clozaril 100mg tablets (Novartis Pharmaceuticals UK Ltd) | drug | res36: Atypical APDs | |||
| 72580020 | Multilex | Clozapine 25mg tablets | drug | res36: Atypical APDs | |||
| 72581020 | Multilex | Clozapine 100mg tablets | drug | res36: Atypical APDs | |||
| 73439020 | Multilex | Remoxipride 150mg capsule | drug | res36: Atypical APDs | |||
| 73440020 | Multilex | Remoxipride 300mg capsule | drug | res36: Atypical APDs | |||
| 73441020 | Multilex | Remoxipride 75mg capsule | drug | res36: Atypical APDs | |||
| 73474020 | Multilex | Roxiam 150mg Capsule (AstraZeneca UK Ltd) | drug | res36: Atypical APDs | |||
| 73475020 | Multilex | Roxiam 300mg Capsule (AstraZeneca UK Ltd) | drug | res36: Atypical APDs | |||
| 73798020 | Multilex | Risperdal 4mg tablets (Janssen-Cilag Ltd) | drug | res36: Atypical APDs | |||
| 73799020 | Multilex | Risperdal 1mg/ml liquid (Janssen-Cilag Ltd) | drug | res36: Atypical APDs | |||
| 73800020 | Multilex | Risperdal 6mg tablets (Janssen-Cilag Ltd) | drug | res36: Atypical APDs | |||
| 74786020 | Multilex | Risperidone 500microgram tablets (Actavis UK Ltd) | drug | res36: Atypical APDs | |||
| 74841020 | Multilex | Risperidone 1mg tablets (Teva UK Ltd) | drug | res36: Atypical APDs | |||
| 74927020 | Multilex | Risperidone 500microgram tablets (A A H Pharmaceuticals Ltd) | drug | res36: Atypical APDs | |||
| 77501020 | Multilex | Risperdal Quicklet 2mg orodispersible tablets (Janssen-Cilag Ltd) | drug | res36: Atypical APDs | |||
| 77550020 | Multilex | Risperdal Consta 37.5mg powder and solvent for suspension for injection vials (Janssen-Cilag Ltd) | drug | res36: Atypical APDs | |||
| 77749020 | Multilex | Risperdal 500microgram tablets (Janssen-Cilag Ltd) | drug | res36: Atypical APDs | |||
| 77912020 | Multilex | Risperidone 500microgram tablets | drug | res36: Atypical APDs | |||
| 78753020 | Multilex | Risperdal Consta 25mg powder and solvent for suspension for injection vials (Janssen-Cilag Ltd) | drug | res36: Atypical APDs | |||
| 78912020 | Multilex | Zyprexa 5mg Velotabs (Eli Lilly and Company Ltd) | drug | res36: Atypical APDs | |||
| 78913020 | Multilex | Zyprexa 10mg Velotabs (Eli Lilly and Company Ltd) | drug | res36: Atypical APDs | |||
| 79348020 | Multilex | Solian 100mg/ml oral solution (Sanofi) | drug | res36: Atypical APDs | |||
| 79476020 | Multilex | Risperidone 1mg orodispersible tablets sugar free | drug | res36: Atypical APDs | |||
| 79499020 | Multilex | Zyprexa 15mg Velotabs (Eli Lilly and Company Ltd) | drug | res36: Atypical APDs | |||
| 80139020 | Multilex | Amisulpride 100mg tablets | drug | res36: Atypical APDs | |||
| 80154020 | Multilex | Solian 100 tablets (Sanofi) | drug | res36: Atypical APDs | |||
| 81008020 | Multilex | Zyprexa 2.5mg tablets (Eli Lilly and Company Ltd) | drug | res36: Atypical APDs | |||
| 81014020 | Multilex | Olanzapine 2.5mg tablets | drug | res36: Atypical APDs | |||
| 81015020 | Multilex | Olanzapine 5mg Orodispersible tablet | drug | res36: Atypical APDs | |||
| 81016020 | Multilex | Olanzapine 10mg Orodispersible tablet | drug | res36: Atypical APDs | |||
| 81543020 | Multilex | Risperidone 2mg orodispersible tablets sugar free | drug | res36: Atypical APDs | |||
| 81545020 | Multilex | Risperdal Quicklet 1mg orodispersible tablets (Janssen-Cilag Ltd) | drug | res36: Atypical APDs | |||
| 81945020 | Multilex | Amisulpride 100mg/ml oral solution sugar free | drug | res36: Atypical APDs | |||
| 82616020 | Multilex | Risperdal Consta 50mg powder and solvent for suspension for injection vials (Janssen-Cilag Ltd) | drug | res36: Atypical APDs | |||
| 82827020 | Multilex | Sertindole 4mg tablets | drug | res36: Atypical APDs | |||
| 82828020 | Multilex | Sertindole 12mg tablets | drug | res36: Atypical APDs | |||
| 82829020 | Multilex | Sertindole 16mg tablets | drug | res36: Atypical APDs | |||
| 82831020 | Multilex | Sertindole 20mg tablets | drug | res36: Atypical APDs | |||
| 82835020 | Multilex | Serdolect 4mg tablets (Lundbeck Ltd) | drug | res36: Atypical APDs | |||
| 82836020 | Multilex | Serdolect 12mg tablets (Lundbeck Ltd) | drug | res36: Atypical APDs | |||
| 82837020 | Multilex | Serdolect 16mg tablets (Lundbeck Ltd) | drug | res36: Atypical APDs | |||
| 83397020 | Multilex | Zyprexa 5mg tablets (Eli Lilly and Company Ltd) | drug | res36: Atypical APDs | |||
| 83398020 | Multilex | Zyprexa 7.5mg tablets (Eli Lilly and Company Ltd) | drug | res36: Atypical APDs | |||
| 83399020 | Multilex | Zyprexa 10mg tablets (Eli Lilly and Company Ltd) | drug | res36: Atypical APDs | |||
| 83403020 | Multilex | Olanzapine 5mg tablets | drug | res36: Atypical APDs | |||
| 83404020 | Multilex | Olanzapine 7.5mg tablets | drug | res36: Atypical APDs | |||
| 83405020 | Multilex | Olanzapine 10mg tablets | drug | res36: Atypical APDs | |||
| 84528020 | Multilex | Roxiam ir 75mg Capsule (AstraZeneca UK Ltd) | drug | res36: Atypical APDs | |||
| 85202020 | Multilex | Quetiapine Starter Pack | drug | res36: Atypical APDs | |||
| 85203020 | Multilex | Quetiapine 25mg tablets | drug | res36: Atypical APDs | |||
| 85204020 | Multilex | Quetiapine 100mg tablets | drug | res36: Atypical APDs | |||
| 85206020 | Multilex | Quetiapine 200mg tablets | drug | res36: Atypical APDs | |||
| 85207020 | Multilex | Quetiapine 150mg tablets | drug | res36: Atypical APDs | |||
| 85212020 | Multilex | Seroquel 25mg tablets (AstraZeneca UK Ltd) | drug | res36: Atypical APDs | |||
| 85213020 | Multilex | Seroquel 100mg tablets (AstraZeneca UK Ltd) | drug | res36: Atypical APDs | |||
| 85215020 | Multilex | Seroquel 200mg tablets (AstraZeneca UK Ltd) | drug | res36: Atypical APDs | |||
| 85216020 | Multilex | Seroquel 150mg tablets (AstraZeneca UK Ltd) | drug | res36: Atypical APDs | |||
| 85992020 | Multilex | Amisulpride 50mg tablets | drug | res36: Atypical APDs | |||
| 85993020 | Multilex | Amisulpride 200mg tablets | drug | res36: Atypical APDs | |||
| 85994020 | Multilex | Amisulpride 400mg tablets | drug | res36: Atypical APDs | |||
| 85999020 | Multilex | Solian 50 tablets (Sanofi) | drug | res36: Atypical APDs | |||
| 86000020 | Multilex | Solian 200 tablets (Sanofi) | drug | res36: Atypical APDs | |||
| 86001020 | Multilex | Solian 400 tablets (Sanofi) | drug | res36: Atypical APDs | |||
| 86494020 | Multilex | Risperidone 25mg powder and solvent for suspension for injection vials | drug | res36: Atypical APDs | |||
| 86496020 | Multilex | Risperidone 37.5mg powder and solvent for suspension for injection vials | drug | res36: Atypical APDs | |||
| 87045020 | Multilex | Quetiapine 300mg tablets | drug | res36: Atypical APDs | |||
| 87047020 | Multilex | Seroquel 300mg tablets (AstraZeneca UK Ltd) | drug | res36: Atypical APDs | |||
| 87556020 | Multilex | Olanzapine 10mg powder for solution for injection vials | drug | res36: Atypical APDs | |||
| 87558020 | Multilex | Zyprexa 10mg powder for solution for injection vials (Eli Lilly and Company Ltd) | drug | res36: Atypical APDs | |||
| 87944020 | Multilex | Aripiprazole 10mg tablets | drug | res36: Atypical APDs | |||
| 87946020 | Multilex | Aripiprazole 15mg tablets | drug | res36: Atypical APDs | |||
| 87948020 | Multilex | Aripiprazole 30mg tablets | drug | res36: Atypical APDs | |||
| 87950020 | Multilex | Abilify 10mg tablets (Otsuka Pharmaceuticals (U.K.) Ltd) | drug | res36: Atypical APDs | |||
| 87952020 | Multilex | Abilify 15mg tablets (Otsuka Pharmaceuticals (U.K.) Ltd) | drug | res36: Atypical APDs | |||
| 87954020 | Multilex | Abilify 30mg tablets (Otsuka Pharmaceuticals (U.K.) Ltd) | drug | res36: Atypical APDs | |||
| 88167020 | Multilex | Denzapine 25mg tablets (Britannia Pharmaceuticals Ltd) | drug | res36: Atypical APDs | |||
| 88169020 | Multilex | Denzapine 100mg tablets (Britannia Pharmaceuticals Ltd) | drug | res36: Atypical APDs | |||
| 88666020 | Multilex | Aripiprazole 5mg tablets | drug | res36: Atypical APDs | |||
| 88668020 | Multilex | Abilify 5mg tablets (Otsuka Pharmaceuticals (U.K.) Ltd) | drug | res36: Atypical APDs | |||
| 88804020 | Multilex | Zaponex 25mg tablets (Teva UK Ltd) | drug | res36: Atypical APDs | |||
| 88806020 | Multilex | Zaponex 100mg tablets (Teva UK Ltd) | drug | res36: Atypical APDs | |||
| 88875020 | Multilex | Risperidone 500microgram orodispersible tablets sugar free | drug | res36: Atypical APDs | |||
| 88877020 | Multilex | Risperdal Quicklet 500microgram orodispersible tablets (Janssen-Cilag Ltd) | drug | res36: Atypical APDs | |||
| 89950020 | Multilex | Amisulpride 25mg/5ml oral suspension | drug | res36: Atypical APDs | |||
| 90165020 | Multilex | Olanzapine 20mg Orodispersible tablet | drug | res36: Atypical APDs | |||
| 90167020 | Multilex | Zyprexa 20mg Velotabs (Eli Lilly and Company Ltd) | drug | res36: Atypical APDs | |||
| 91139020 | Multilex | Aripiprazole 10mg orodispersible tablets sugar free | drug | res36: Atypical APDs | |||
| 91141020 | Multilex | Aripiprazole 15mg orodispersible tablets sugar free | drug | res36: Atypical APDs | |||
| 91143020 | Multilex | Aripiprazole 1mg/ml oral solution | drug | res36: Atypical APDs | |||
| 91145020 | Multilex | Abilify 10mg orodispersible tablets (Otsuka Pharmaceuticals (U.K.) Ltd) | drug | res36: Atypical APDs | |||
| 91147020 | Multilex | Abilify 15mg orodispersible tablets (Otsuka Pharmaceuticals (U.K.) Ltd) | drug | res36: Atypical APDs | |||
| 91149020 | Multilex | Abilify 1mg/ml oral solution (Otsuka Pharmaceuticals (U.K.) Ltd) | drug | res36: Atypical APDs | |||
| 92053020 | Multilex | Olanzapine 20mg tablets | drug | res36: Atypical APDs | |||
| 92055020 | Multilex | Zyprexa 20mg tablets (Eli Lilly and Company Ltd) | drug | res36: Atypical APDs | |||
| 92717020 | Multilex | Risperidone 3mg orodispersible tablets sugar free | drug | res36: Atypical APDs | |||
| 92721020 | Multilex | Risperidone 4mg orodispersible tablets sugar free | drug | res36: Atypical APDs | |||
| 92723020 | Multilex | Risperdal Quicklet 3mg orodispersible tablets (Janssen-Cilag Ltd) | drug | res36: Atypical APDs | |||
| 92725020 | Multilex | Risperdal Quicklet 4mg orodispersible tablets (Janssen-Cilag Ltd) | drug | res36: Atypical APDs | |||
| 93739020 | Multilex | Paliperidone 3mg modified-release tablets | drug | res36: Atypical APDs | |||
| 93741020 | Multilex | Paliperidone 6mg modified-release tablets | drug | res36: Atypical APDs | |||
| 93743020 | Multilex | Paliperidone 9mg modified-release tablets | drug | res36: Atypical APDs | |||
| 93747020 | Multilex | Invega 6mg modified-release tablets (Janssen-Cilag Ltd) | drug | res36: Atypical APDs | |||
| 94787020 | Multilex | Quetiapine 50mg modified-release tablets | drug | res36: Atypical APDs | |||
| 94789020 | Multilex | Quetiapine 200mg modified-release tablets | drug | res36: Atypical APDs | |||
| 94791020 | Multilex | Quetiapine 300mg modified-release tablets | drug | res36: Atypical APDs | |||
| 94793020 | Multilex | Quetiapine 400mg modified-release tablets | drug | res36: Atypical APDs | |||
| 94971020 | Multilex | Aripiprazole 9.75mg/1.3ml solution for injection vials | drug | res36: Atypical APDs | |||
| 94973020 | Multilex | Abilify 9.75mg/1.3ml solution for injection vials (Otsuka Pharmaceuticals (U.K.) Ltd) | drug | res36: Atypical APDs | |||
| 95787020 | Multilex | Seroquel XL 50mg tablets (AstraZeneca UK Ltd) | drug | res36: Atypical APDs | |||
| 95789020 | Multilex | Seroquel XL 200mg tablets (AstraZeneca UK Ltd) | drug | res36: Atypical APDs | |||
| 95791020 | Multilex | Seroquel XL 300mg tablets (AstraZeneca UK Ltd) | drug | res36: Atypical APDs | |||
| 95793020 | Multilex | Seroquel XL 400mg tablets (AstraZeneca UK Ltd) | drug | res36: Atypical APDs | |||
| 97145020 | Multilex | Clozapine 50mg tablets | drug | res36: Atypical APDs | |||
| 97147020 | Multilex | Denzapine 50mg tablets (Britannia Pharmaceuticals Ltd) | drug | res36: Atypical APDs | |||
| 97149020 | Multilex | Clozapine 200mg tablets | drug | res36: Atypical APDs | |||
| 97151020 | Multilex | Denzapine 200mg tablets (Britannia Pharmaceuticals Ltd) | drug | res36: Atypical APDs | |||
| 97153020 | Multilex | Clozapine 50mg/ml oral suspension sugar free | drug | res36: Atypical APDs | |||
| 97155020 | Multilex | Denzapine 50mg/ml oral suspension (Britannia Pharmaceuticals Ltd) | drug | res36: Atypical APDs | |||
| 97203020 | Multilex | Quetiapine 100mg/5ml oral solution | drug | res36: Atypical APDs | |||
| 97205020 | Multilex | Quetiapine 100mg/5ml oral suspension | drug | res36: Atypical APDs | |||
| 98873020 | Multilex | Quetiapine 150mg modified-release tablets | drug | res36: Atypical APDs | |||
| 98875020 | Multilex | Seroquel XL 150mg tablets (AstraZeneca UK Ltd) | drug | res36: Atypical APDs | |||
| 99745020 | Multilex | Quetiapine 25mg/5ml oral suspension | drug | res36: Atypical APDs |
Please log in to leave a comment.
Code list links:
ClinicalCodes is a project at the University of Manchester Institute of Population Health
The ClinicalCodes project is funded by the National Institute for Health Research (NIHR) School for Primary Care Research (SPCR)